Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Anesthesia|April 6, 2018
Incidence of hypersensitivity and anaphylaxis with sugammadexK Chris Min, Tiffany Woo, Christopher Assaid, et al.
Journal of Clinical Psychopharmacology|June 23, 2012
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderLobna Ibrahim, Nancy Diaz Granados, Libby Jolkovsky, et al.
BMC Anesthesiology|October 29, 2021
A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participantsW Joseph Herring, Yuki Mukai, Aobo Wang, et al.
The Journal of Clinical Psychiatry|August 21, 2012
Randomized controlled study of the histamine H3 inverse agonist MK-0249 in adult attention-deficit/hyperactivity disorderW Joseph Herring, Timothy E Wilens, Lenard A Adler, et al.
The International Journal of Neuropsychopharmacology|March 17, 2016
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary InsomniaKathryn M Connor, Erin Mahoney, Saheeda Jackson, et al.
The International Journal of Neuropsychopharmacology|June 6, 2017
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive DisorderKathryn M Connor, Paulette Ceesay, Jill Hutzelmann, et al.
JAMA Network Open|August 16, 2024
Suvorexant for Reduction of Delirium in Older Adults After Hospitalization: A Randomized Clinical TrialKotaro Hatta, Yasuhiro Kishi, Ken Wada, et al.
Advances in Therapy|March 3, 2017
Deep Neuromuscular Blockade Improves Laparoscopic Surgical Conditions: A Randomized, Controlled StudyJacob Rosenberg, W Joseph Herring, Manfred Blobner, et al.
Pageof 4